GE HealthCare Technologies Inc. (GEHC) stock
GEHCNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/308% below fair value
$83.66+1.82 (+2.22%)
Close on Nov 18, 2026Market cap $37.83BP/E 17.6Yield 0.17%
GE HealthCare Technologies revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
GE HealthCare Technologies's revenue for the twelve months ending Sep 30, 2026 was $21.64B, up 6.9% year over year. For fiscal 2025 it was $20.63B, up 4.8% from the year before. The highest annual figure on record is $20.63B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.63B | +4.8% |
| FY2024 | Dec 31, 2024 | $19.67B | +0.6% |
| FY2023 | Dec 31, 2023 | $19.55B | +6.6% |
| FY2022 | Dec 31, 2022 | $18.34B | +4.3% |
| FY2021 | Dec 31, 2021 | $17.59B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $5.51B | +7.2% |
| Q2 FY2026 | Jun 30, 2026 | $5.30B | +5.8% |
| Q1 FY2026 | Mar 31, 2026 | $5.13B | +7.4% |
| Q4 FY2025 | Dec 31, 2025 | $5.70B | +7.1% |
| Q3 FY2025 | Sep 30, 2025 | $5.14B | +5.8% |
| Q2 FY2025 | Jun 30, 2025 | $5.01B | +3.5% |
| Q1 FY2025 | Mar 31, 2025 | $4.78B | +2.7% |
| Q4 FY2024 | Dec 31, 2024 | $5.32B | +2.2% |
| Q3 FY2024 | Sep 30, 2024 | $4.86B | +0.9% |
| Q2 FY2024 | Jun 30, 2024 | $4.84B | +0.5% |
| Q1 FY2024 | Mar 31, 2024 | $4.65B | -1.2% |
| Q4 FY2023 | Dec 31, 2023 | $5.21B | +5.4% |
| Q3 FY2023 | Sep 30, 2023 | $4.82B | +5.4% |
| Q2 FY2023 | Jun 30, 2023 | $4.82B | +7.4% |
| Q1 FY2023 | Mar 31, 2023 | $4.71B | +8.4% |
| Q4 FY2022 | Dec 31, 2022 | $4.94B | – |
| Q3 FY2022 | Sep 30, 2022 | $4.58B | – |
| Q2 FY2022 | Jun 30, 2022 | $4.48B | – |
| Q1 FY2022 | Mar 31, 2022 | $4.34B | – |
See a number that looks wrong?